Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP607771.RAOBkbK-EDNgh2fJvY0hboclN2xKBMzoJi6ZvwayANpNg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP607771.RAOBkbK-EDNgh2fJvY0hboclN2xKBMzoJi6ZvwayANpNg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP607771.RAOBkbK-EDNgh2fJvY0hboclN2xKBMzoJi6ZvwayANpNg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP607771.RAOBkbK-EDNgh2fJvY0hboclN2xKBMzoJi6ZvwayANpNg130_provenance.
- NP607771.RAOBkbK-EDNgh2fJvY0hboclN2xKBMzoJi6ZvwayANpNg130_assertion description "[Forty-one patients with a first episode of a retinal artery occlusion underwent complete ophthalmic examination, routine blood testing and specific laboratory tests for thrombophilia, such as fasting and postmethionine homocysteine, lipoprotein(a), plasminogen activator inhibitor-1, factor VIII, factor V Leiden, factor II G20210A polymorphism, lupus anticoagulant and anticardiolipin antibodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP607771.RAOBkbK-EDNgh2fJvY0hboclN2xKBMzoJi6ZvwayANpNg130_provenance.
- NP607771.RAOBkbK-EDNgh2fJvY0hboclN2xKBMzoJi6ZvwayANpNg130_assertion evidence source_evidence_literature NP607771.RAOBkbK-EDNgh2fJvY0hboclN2xKBMzoJi6ZvwayANpNg130_provenance.
- NP607771.RAOBkbK-EDNgh2fJvY0hboclN2xKBMzoJi6ZvwayANpNg130_assertion SIO_000772 17473572 NP607771.RAOBkbK-EDNgh2fJvY0hboclN2xKBMzoJi6ZvwayANpNg130_provenance.
- NP607771.RAOBkbK-EDNgh2fJvY0hboclN2xKBMzoJi6ZvwayANpNg130_assertion wasDerivedFrom befree-2016 NP607771.RAOBkbK-EDNgh2fJvY0hboclN2xKBMzoJi6ZvwayANpNg130_provenance.
- NP607771.RAOBkbK-EDNgh2fJvY0hboclN2xKBMzoJi6ZvwayANpNg130_assertion wasGeneratedBy ECO_0000203 NP607771.RAOBkbK-EDNgh2fJvY0hboclN2xKBMzoJi6ZvwayANpNg130_provenance.
- befree-2016 importedOn "2016-02-19" NP607771.RAOBkbK-EDNgh2fJvY0hboclN2xKBMzoJi6ZvwayANpNg130_provenance.